Concepedia
Statistics
Publications
10
Citations
417
H-Index
Active since
2015
Affiliations
Fujian Medical University(Current)
Beth Israel Deaconess Medical Center
Translational Therapeutics (United States)
Cancer Research Institute
First Affiliated Hospital of Fujian Medical University
Wenxian Lu is an author at Fujian Medical University specializing in medicine, molecular oncology, and cancer cell signaling.
Publications per year
2015–2021
Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway
Jichuang Wang, Nan Zhang, Qi Han et al. · Cancer Letters · 2018 · 109 citations
Medicine, Oncology, Pharmacology +16
A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways
Dayun Yang, Wensong Luo, Jichuang Wang et al. · Journal of Controlled Release · 2017 · 75 citations · Full text
Pharmacy, Oncology, Pharmacology +16
Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways
Xin-Hua Liao, Arina Li Zhang, Min Zheng et al. · Scientific Reports · 2017 · 53 citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma
Min Zheng, Huijuan Xu, Xin‐Hua Liao et al. · Oncotarget · 2017 · 38 citations · Full text
Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β‐catenin oncogenic pathways
Zhenzhen Zhang, Weixing Yu, Min Zheng et al. · Molecular Carcinogenesis · 2019 · 36 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 10